logo
Fed Rate Cut More Likely in Fourth Quarter, UBP's Nip Says

Fed Rate Cut More Likely in Fourth Quarter, UBP's Nip Says

Bloomberg3 days ago
The China Show
UBP's Anitza Nip says a rate cut by the US Federal Reserve "could happen in the fourth quarter, not in the July meeting." She discusses her views on fixed income opportunities on Bloomberg Television. (Source: Bloomberg)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area
CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

Yahoo

time5 minutes ago

  • Yahoo

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 21, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, underscoring strong demand within China's thriving pharma industry. Building on this success, CPHI & PMEC Shenzhen 2025 will take place from 1–3 September 2025 at Shenzhen Convention & Exhibition Center (SZCEC), addressing the growing demand for access to South China's key pharma markets. As a key gateway to the Guangdong-Hong Kong-Macau Greater Bay Area, Shenzhen is positioned to drive pharma innovation. The region's health industry GDP is projected to surpass 2 trillion CNY by 2028 and reach 2.5 trillion to 3 trillion CNY by 2030, offering unparalleled opportunities for growth and collaboration. CPHI & PMEC Shenzhen is set to achieve remarkable growth in 2025, doubling its size to 30,000 sqm of show floor and featuring over 600 selected exhibiting companies from various sectors of the pharmaceutical industry, including pharma ingredients, excipients, biotech, contract services, pharma machinery, packaging machinery, packaging materials and more. The event will expand product zones for natural supply, finished dosage, clean technology and laboratory instruments. A new 'Beauty & Cosmetics Supply Chain Zone' will showcase products and foster collaboration in this rapidly growing sector. During the exhibition, over 20 high-level forums will bring together regulatory authorities, academic experts, and corporate leaders to deliver in-depth analysis of policy shifts, technological breakthroughs, and emerging market dynamics. Key topics include new drug R&D, API process optimisation, CXO collaborations, emerging markets strategy, nutrition and health food development, natural ingredients and functional food development, injectable medical aesthetics innovation, pharma packaging solutions, pharma manufacturing 4.0, pharmaceutical engineering and more. To forge strategic partnerships, exclusive Hosted Buyer Matchmaking and Plant visit will be organized. These initiatives will facilitate meaningful interactions between suppliers and international buyers with specific purchasing demand. With its strategic location and curated focus, CPHI & PMEC Shenzhen 2025 is set to redefine pharma innovation in South China. The event offers unparalleled opportunities for networking, knowledge exchange, and collaboration, empowering attendees to unlock new growth horizons across Asia's thriving pharmaceutical sector. Register as a visitor before 1 August to enjoy complimentary VIP benefits: For more information, please visit: View original content to download multimedia: SOURCE CPHI & PMEC Shenzhen

Japan's PM Ishiba says he will stay in office despite election loss
Japan's PM Ishiba says he will stay in office despite election loss

Yahoo

time5 minutes ago

  • Yahoo

Japan's PM Ishiba says he will stay in office despite election loss

Japanese Prime Minister Shigeru Ishiba has said he will stay in office to tackle challenges such as rising prices and high US tariffs after a weekend election defeat left his coalition with a minority in both parliamentary chambers. Mr Ishiba's ruling Liberal Democratic Party (LDP) and its junior coalition partner Komeito were three seats short of maintaining a majority in the 248-seat upper house in Sunday's vote. The coalition is now a minority in both houses of the Diet, or parliament, though the LDP is still the leading party. Mr Ishiba said he takes the result seriously but that his priority is to avoid creating a political vacuum and to tackle impending challenges, including the August 1 deadline for a tariff deal with the US. 'While I painfully feel my serious responsibility over the election results, I believe I must also fulfil my responsibility I bear for the country and the people so as not to cause politics to stall or go adrift,' Mr Ishiba said. 'Challenges such as global situation and natural disaster won't wait for a better political situation.' The prime minister said he hopes to reach a mutually beneficial deal and meet with US President Donald Trump. Sunday's vote comes after Mr Ishiba's coalition lost a majority in the October lower house election, stung by past corruption scandals, and his unpopular government has since been forced into making concessions to the opposition to get legislation through parliament. It has been unable to quickly deliver effective measures to mitigate rising prices, including Japan's traditional staple of rice, and dwindling wages. Mr Trump has added to the pressure, complaining about a lack of progress in trade negotiations and the lack of sales of US cars and American-grown rice to Japan despite a shortfall in domestic stocks of the grain. A 25% tariff due to take effect on August 1 has been another blow for Mr Ishiba.

Chinese exports of two critical minerals plunge even as rare earths rebound
Chinese exports of two critical minerals plunge even as rare earths rebound

Yahoo

time5 minutes ago

  • Yahoo

Chinese exports of two critical minerals plunge even as rare earths rebound

By Lewis Jackson BEIJING (Reuters) -China's exports of two critical minerals used in weapons, telecommunications and solar cells have plunged over the past three months amid a crackdown on smuggling and transshipment that has involved China's top spy agency. Exports of antimony and germanium in June were down 88% and 95%, respectively, versus January, according to customs data published on Sunday. Much as with rare earths, China is by far the largest miner and or refiner for both elements. Both were added to an export control list in 2023 and 2024, respectively. Exports to the U.S. were then banned in December as part of retaliation for chip restrictions. Rare earths were added to the same control list in April, precipitating a sharp collapse in export volumes that forced some carmakers in Europe and the U.S. to pause some production lines. But where rare earth export volumes rebounded sharply last month thanks to a deal struck between Washington and Beijing, exports of germanium and antimony fell to some of the lowest levels on record. The collapse in export volumes coincides with well-publicised crackdown on critical mineral export control evasion. China's spy agency said last week it had detected attempts to bypass controls via transshipment, where cargoes move through a third country before going on to their final destination. The week before Reuters reported that unusually large quantities of antimony were being exported to the United States from Thailand and Mexico in what appeared to be transshipment conducted by at least one Chinese company. China's exports of antimony to Thailand have collapsed by 90% after hitting a record in April. There have been no exports to Mexico since April. Spot market prices for high-purity germanium have more than doubled since China imposed export restrictions in July 2023. Antimony prices have nearly quadrupled from May last year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store